Meet the Committee Members
Meet the Committee Members
The Women’s Venture Competition review committees are comprised of a combination of world-class life sciences industry professionals, investors and entrepreneurs from within the extensive network of the National Foundation for Cancer Research, the non-profit affiliate of the AIM-HI Accelerator Fund.
This competition is designed to provide women scientist-entrepreneurs with advising, coaching and continuous access to our valuable global network to advance their innovative oncology technologies that can save patients’ lives. Ready to do more? DONATE NOW and help us double the impact for women scientist-entrepreneurs who are creating life-saving oncology innovations!
Judging Committee
Anna D. Barker, Ph.D. | Co-Chair
Chief Strategy Officer, Ellison Institute of Technology
Raju Kucherlapati, Ph.D. | Co-Chair
Paul C. Cabot Professor of Genetics & Professor of Medicine, Harvard Medical School
Webster Cavenee, Ph.D.
Distinguished Professor Emeritus, University of California, San Diego
Aleksandra Filipovic, M.D., Ph.D.
Head of Oncology, PureTech Health
Gary Gordon, M.D., Ph.D.
Senior Medical Advisor and Board Member, Global Coalition for Adaptive Research
Scott Lippman, M.D.
Distinguished Professor of Medicine & Associate Vice Chancellor for Cancer Research
Eva Martin, M.D.
Senior Director, Alliance and Asset Management, Roche Pharma Partnering
Tom Miller
Founder & Managing Partner, GreyBird Ventures
Professor of Medicine, Dana-Farber Cancer Institute
Libia F. Scheller, Ph.D., MBA
Global Head Oncology-Cooperative Groups & Strategic Alliances, Bayer Health Care Pharmaceuticals
Selection Committee
Pamela Garzone, Ph.D. | Co-Chair
Chief Development Officer, Anixa Biosciences
Paul C. Cabot Professor of Genetics & Professor of Medicine, Harvard Medical School
Distinguished Professor Emeritus, University of California, San Diego
Head of Oncology, PureTech Health
Daniel Johnson, Ph.D.
Professor and Vice Chair of Research, Department of Otolaryngology, UC San Francisco
Matthew Lawler
Entrepreneur-In-Residence, Blackbird Laboratories
Scott Lippman, M.D.
Distinguished Professor of Medicine & Associate Vice Chancellor for Cancer Research
Eva Martin, M.D.
Senior Director, Alliance and Asset Management, Roche Pharma Partnering
Kornelia Polyak, M.D., Ph.D.
Professor of Medicine, Dana-Farber Cancer Institute
Michael Salgaller, Ph.D.
Supervisory Invention Development & Marketing Specialist, National Institutes of Health/National Cancer Institute
Fei Shen, Ph.D.
Managing Director, Boehringer Ingelheim Venture Fund USA
Matt Tremblay, Ph.D.
CEO, Blackbird Laboratories
